Nova Leah develop expert cybersecurity risk assessment solutions specific for connected medical devices.
Nova Leah believe in excellence through knowledge development, sharing and collaboration to enhance the security assurance of medical devices. Nova Leah's product, SelectEvidence, is an intelligent cybersecurity risk management compliance solution aimed at medical device manufacturers and healthcare providers.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 7, 2021 | Series Unknown | — | 3 |
![]() |
— | Detail |
Mar 4, 2019 | Series Unknown | €3.70M | — | — | — | Detail |
Nov 8, 2018 | Series Unknown | €2.25M | 3 |
![]() |
— | Detail |
Oct 12, 2017 | Series Unknown | €500K | 2 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Series Unknown |
![]() |
Yes | Series Unknown |
![]() |
— | Series Unknown |
![]() |
— | Series Unknown |
![]() |
— | Series Unknown |